ARTICLE
- BARRONS
(2020)
The company said it is sponsoring a 400-patient randomized trial to confirm whether the drug Olumiant can moderate Covid symptoms.
—-
“... The idea that Eli Lilly ’s arthritis drug Olumiant might help Covid-19 patients emerged from an artificial-intelligence survey of approved drugs...
Visibility: Public (all visitors)
Comments
Related Chunks
Related chunks with this resource
Artificial intelligence AI and drug research, medicine and health care
Treating the symptoms - Researching Possible Treatments for COVID19 - Coronavirus
No comments yet. Be the first to comment!